
Suzhou Weibang Zhendian Optoelectronics Technology
Optical & acoustic imaging and sensing technology for surgical guidiance and diangosis.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
* | CNY100m | Series A | |
Total Funding | 000k |
Related Content
Vibronix Inc. specializes in developing advanced medical imaging devices, particularly for ultrasound-guided procedures. The company's flagship product, AcuSee, is a guidance system that assists in visualizing and displaying the trajectory and orientation of instruments such as biopsy needles, aspiration needles, and ablation needles within ultrasound images. This technology aims to reduce the difficulty, improve the accuracy, and shorten the learning curve for ultrasound-guided procedures. Vibronix operates primarily in the medical technology market, serving healthcare providers and medical professionals who require precise imaging solutions for interventional procedures. The company's business model revolves around the development, FDA approval, and commercialization of its innovative medical devices. Revenue is generated through the sale of these devices to hospitals, clinics, and other healthcare facilities. Vibronix's competitive edge lies in its ability to integrate cutting-edge optical spectroscopic imaging techniques with practical medical applications, a feat achieved under the scientific guidance of renowned experts like Dr. Ji Xin Cheng. The company continues to push the boundaries of medical imaging technology, aiming to bring science fiction concepts like the tricorder from Star Trek into real-world medical practice.
Keywords: ultrasound guidance, medical imaging, AcuSee, biopsy needle, aspiration needle, ablation needle, FDA clearance, surgical navigation, interventional procedures, healthcare technology.